ArticleJournal for immunotherapy of cancer2024

Network-based screening identifies sitagliptin as an antitumor drug targeting dendritic cells.

Ian-Ian Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.